LAM
EBS icon

L2 Asset Management’s Emergent Biosolutions EBS Stock Holding History

L2 Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$214K Buy
25,782
+15,181
+143% +$157K 0.02% 372
2025
Q4 		$131K Buy
10,601
+421
+4% +$4.51K 0.02% 359
2025
Q3 		$89.8K Sell
10,180
-1,782
-15% -$13.9K 0.01% 360
2025
Q2 		$76.3K Buy
+11,962
New +$68.5K 0.01% 357

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

L2 Asset Management's EBS Position: Q1 2026 in Review

L2 Asset Management increased its Emergent Biosolutions (EBS) stake by 143% in Q1 2026, buying an estimated $157K and bringing the position to 25,782 shares worth $214K. The position accounts for 0.02% of the portfolio, ranked #372.

L2 Asset Management first reported a position in EBS in Q2 2025 and has held it in 4 quarters since. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • L2 Asset Management held 25,782 shares of Emergent Biosolutions worth $214K as of Q1 2026.
  • L2 Asset Management bought 15,181 Emergent Biosolutions shares in Q1 2026, an estimated $157K.
  • Emergent Biosolutions made up 0.02% of L2 Asset Management's portfolio in Q1 2026, its #372 holding.
  • L2 Asset Management first reported a position in Emergent Biosolutions in Q2 2025 and has held it in 4 quarters since.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on L2 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.